The Alzheimer’s Treatment Controversy: Implications of Accelerated Drug Approvals Live Online Q&A with Aaron Kesselheim, Professor of Medicine, Harvard Medical School, and Director, Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women’s Hospital Presented jointly with Reuters Tuesday, July 20, 2021 The recent controversy surrounding the FDA approval of a new Alzheimer’s treatment has Read More…
THE DR. LAWRENCE H. AND ROBERTA COHN FORUMS U.S. DRUG PRICES: Why Are They So High? Presented jointly with Reuters Brief Video Highlight Wednesday, September 26, 2018 Americans pay more money – sometimes much more money – for prescriptions than consumers in many other wealthy countries. Why? The drivers are many and complicated. Pharmaceutical companies, Read More…
Brief Video Highlight THE 21st CENTURY CURES ACT: Implications for Research and Drug Development Presented jointly with STAT Monday, February 27, 2017 The passage of the 21st Century Cures Act has drawn both applause and criticism. A sweeping bipartisan effort with multiple components, the law dramatically boosts funding for medical research, particularly in areas such Read More…
DRUG PRICING: PUBLIC HEALTH IMPLICATIONS The Dr. Lawrence H. and Roberta Cohn Forums Presented in Collaboration with Reuters and in Association with Harvard Health Publications We are deeply saddened by the loss of Dr. Lawrence H. Cohn, advisor and supporter of this Forum in addition to others in the The Dr. Lawrence H. and Roberta Cohn Read More…
[FORUM VIDEO] This Forum event examined the public health menace posed by antimicrobial resistance and the steps to be undertaken to fight the “superbugs.”
